Advances of CRISPR-Cas Systems for Genome Engineering

A special issue of Methods and Protocols (ISSN 2409-9279).

Deadline for manuscript submissions: closed (30 November 2020) | Viewed by 12503

Special Issue Editor


E-Mail Website
Guest Editor
PlasmoGEM, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK
Interests: My interest and expertise lies in genome engineering, and my research seeks to improve efficiency and accuracy of genome engineering tools, such as CRISPR/Cas9 in a variety of model systems.

Special Issue Information

Dear Colleagues,

Recent years have seen unrivalled advances in our ability to utilize gene editing technologies due to the emergence of CRISPR/Cas systems. From its discovery as a bacterial defence system, it has evolved into a state-of-the-art tool for introducing gene modifications in a variety of model organisms. Researchers have been working tirelessly on improving the system, ensuring better on-target efficiency and reduced off-target activity, implementing novel systems that reduce the occurrence of deleterious side products and improve on delivery and expression efficacy, all with the common aim to utilize the system as a therapeutic tool.

In this Special Issue titled “Advances of CRISPR-Cas Systems for Genome Engineering”, we welcome original and novel research and review articles presenting innovative methodologies utilizing CRISPR-Cas. These can address challenges such as (1) improving the CRISPR system itself, including novel nucleases, base editing, prime editing, and similar systems; (2) refinements on the delivery and expression; and (3) therapeutic applications of CRISPR.

We are looking forward to receiving your research article.

Dr. Katharina Boroviak
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Methods and Protocols is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • genome engineering
  • CRISPR
  • base editors
  • prime editing
  • model systems
  • disease

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Jump to: Other

28 pages, 1262 KiB  
Review
CRISPR-Based Editing Techniques for Genetic Manipulation of Primary T Cells
by Mateusz Kotowski and Sumana Sharma
Methods Protoc. 2020, 3(4), 79; https://doi.org/10.3390/mps3040079 - 18 Nov 2020
Cited by 9 | Viewed by 4523
Abstract
While clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing techniques have been widely adapted for use in immortalised immune cells, efficient manipulation of primary T cells has proved to be more challenging. Nonetheless, the rapid expansion of the CRISPR toolbox accompanied by [...] Read more.
While clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing techniques have been widely adapted for use in immortalised immune cells, efficient manipulation of primary T cells has proved to be more challenging. Nonetheless, the rapid expansion of the CRISPR toolbox accompanied by the development of techniques for delivery of CRISPR components into primary T cells now affords the possibility to genetically manipulate primary T cells both with precision and at scale. Here, we review the key features of the techniques for primary T cell editing and discuss how the new generation of CRISPR-based tools may advance genetic engineering of these immune cells. This improved ability to genetically manipulate primary T cells will further enhance our fundamental understanding of cellular signalling and transcriptional networks in T cells and more importantly has the potential to revolutionise T cell-based therapies. Full article
(This article belongs to the Special Issue Advances of CRISPR-Cas Systems for Genome Engineering)
Show Figures

Figure 1

Other

Jump to: Review

14 pages, 4845 KiB  
Protocol
An Efficient Workflow for Screening and Stabilizing CRISPR/Cas9-Mediated Mutant Lines in Bombyx mori
by Daniel Brady, Alessio Saviane, Silvia Cappellozza and Federica Sandrelli
Methods Protoc. 2021, 4(1), 4; https://doi.org/10.3390/mps4010004 - 29 Dec 2020
Cited by 7 | Viewed by 3681
Abstract
The domestic silkworm Bombyx mori is extensively studied as a model organism for lepidopteran genetics and has an economic value in silk production. Silkworms also have applications in biomedical and cosmetic industries, and the production of mutant B. mori strains significantly enhances basic [...] Read more.
The domestic silkworm Bombyx mori is extensively studied as a model organism for lepidopteran genetics and has an economic value in silk production. Silkworms also have applications in biomedical and cosmetic industries, and the production of mutant B. mori strains significantly enhances basic and applied silkworm research. In recent years, CRISPR/Cas9 technology is being rapidly adopted as the most efficient molecular tool for generating silkworm lines carrying mutations in target genes. Here we illustrate a complete and efficient workflow to screen, characterize rapidly and follow mutations through generations, allowing the generation of B. mori lines, stably inheriting single CRISPR/Cas9-induced mutations. This approach relies on the use of different molecular methods, the heteroduplex assay, cloning followed by Sanger sequencing, and the amplification refractory mutation system PCR. The use of these methodologies in a sequential combination allows the identification of CRISPR/Cas9-induced mutations in genes mapping on both autosomes and sex chromosomes, and the selection of appropriate individuals to found stable mutant B. mori lines. This protocol could be further applied to screen CRISPR/Cas9 mutations in haploid insects. Full article
(This article belongs to the Special Issue Advances of CRISPR-Cas Systems for Genome Engineering)
Show Figures

Graphical abstract

11 pages, 858 KiB  
Technical Note
Unexpectedly High Levels of Inverted Re-Insertions Using Paired sgRNAs for Genomic Deletions
by Joseph Blayney, Evangeline M. Foster, Marta Jagielowicz, Mira Kreuzer, Matteo Morotti, Katharina Reglinski, Julie Huiyuan Xiao and Philip Hublitz
Methods Protoc. 2020, 3(3), 53; https://doi.org/10.3390/mps3030053 - 29 Jul 2020
Cited by 6 | Viewed by 3590
Abstract
Use of dual sgRNAs is a common CRISPR/Cas9-based strategy for the creation of genetic deletions. The ease of screening combined with a rather high rate of success makes this approach a reliable genome engineering procedure. Recently, a number of studies using CRISPR/Cas9 have [...] Read more.
Use of dual sgRNAs is a common CRISPR/Cas9-based strategy for the creation of genetic deletions. The ease of screening combined with a rather high rate of success makes this approach a reliable genome engineering procedure. Recently, a number of studies using CRISPR/Cas9 have revealed unwanted large-scale rearrangements, duplications, inversions or larger-than-expected deletions. Strict quality control measures are required to validate the model system, and this crucially depends on knowing which potential experimental outcomes to expect. Using the dual sgRNA deletion approach, our team discovered high levels of excision, inversion and re-insertion at the site of targeting. We detected those at a variety of genomic loci and in several immortalized cell lines, demonstrating that inverted re-insertions are a common by-product with an overall frequency between 3% and 20%. Our findings imply an inherent danger in the misinterpretation of screening data when using only a single PCR screening. While amplification of the region of interest might classify clones as wild type (WT) based on amplicon size, secondary analyses can discover heterozygous (HET) clones among presumptive WTs, and events deemed as HET clones could potentially be full KO. As such, screening for inverted re-insertions helps in decreasing the number of clones required to obtain a full KO. With this technical note, we want to raise awareness of this phenomenon and suggest implementing a standard secondary PCR while screening for deletions. Full article
(This article belongs to the Special Issue Advances of CRISPR-Cas Systems for Genome Engineering)
Show Figures

Figure 1

Back to TopTop